Pages that link to "Q40962168"
Jump to navigation
Jump to search
The following pages link to Challenges in cyclosporine therapy: the role of therapeutic monitoring by area under the curve monitoring. (Q40962168):
Displaying 50 items.
- New developments in the immunosuppressive drug monitoring of cyclosporine, tacrolimus, and azathioprine (Q32139680) (← links)
- Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicity (Q33332141) (← links)
- Drug substitution in transplantation: a National Kidney Foundation White Paper (Q33534332) (← links)
- The potential role of rapamycin in pediatric transplantation as observed from adult studies (Q33732940) (← links)
- Methods for clinical monitoring of cyclosporin in transplant patients. (Q33937533) (← links)
- Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part I (Q34610933) (← links)
- A rationale for the use of summary measurements for the assessment of the effects of rheumatoid arthritis therapies (Q35174234) (← links)
- A pharmacokinetic and clinical review of the potential clinical impact of using different formulations of cyclosporin A. Berlin, Germany, November 19, 2001. (Q35177677) (← links)
- Cyclosporin in cell therapy for cardiac regeneration (Q35619397) (← links)
- Therapeutic drug monitoring of cyclosporine: 20 years of progress (Q35711332) (← links)
- Evolution of the therapeutic drug monitoring of cyclosporine (Q35711382) (← links)
- Experience with therapeutic drug monitoring of cyclosporine (Q35711395) (← links)
- Bayesian estimation of cyclosporin exposure for routine therapeutic drug monitoring in kidney transplant patients (Q35827273) (← links)
- The impact of age on rejection in kidney transplantation (Q36132592) (← links)
- Effects of oral cyclosporine on canine T-cell expression of IL-2 and IFN-gamma across a 12-h dosing interval (Q36805495) (← links)
- A review on therapeutic drug monitoring of immunosuppressant drugs. (Q38089593) (← links)
- Drug administration in patients with renal insufficiency. Minimising renal and extrarenal toxicity (Q40902529) (← links)
- Pulsed Intra-Arterial Drug Injection during Diastolic Phase of Cardiac Function Increases Drug Efficacy by Enhancing Pharmacological Exposure of Targeted Tissues (Q41089323) (← links)
- Developmental pharmacokinetics of ciclosporin--a population pharmacokinetic study in paediatric renal transplant candidates. (Q42283823) (← links)
- Sirolimus rescue therapy for refractory rejection in renal transplant recipients (Q43552841) (← links)
- Application of a gamma model of absorption to oral cyclosporin (Q43658099) (← links)
- Optimizing Neoral therapeutic drug monitoring with cyclosporine trough (C(0)) and C(2) concentrations in stable renal allograft recipients. (Q43828391) (← links)
- Neoral dose monitoring with cyclosporine 2-hour postdose levels (C(2)) in different renal transplant patient age groups (Q43828395) (← links)
- Population pharmacokinetic model to predict steady-state exposure to once-daily cyclosporin microemulsion in renal transplant recipients (Q43875081) (← links)
- Maximum a posteriori Bayesian estimation of oral cyclosporin pharmacokinetics in patients with stable renal transplants (Q43875084) (← links)
- A limited sampling strategy for the estimation of 12-hour Neoral systemic drug exposure in heart transplant recipients (Q44136543) (← links)
- Determination of serine/threonine protein phosphatase type 2B PP2B in lymphocytes by HPLC. (Q44247189) (← links)
- Neoral monitoring by limited sampling area under the concentration time curve in stable indian renal transplant recipients (Q44491040) (← links)
- Comparison of peak and trough level monitoring of cyclosporine treatment using two modern cyclosporine preparations. (Q44491043) (← links)
- Curcumin enhances the immunosuppressive activity of cyclosporine in rat cardiac allografts and in mixed lymphocyte reactions (Q44491144) (← links)
- Clinical pharmacokinetics of tacrolimus in heart transplantation: new strategies of monitoring (Q44577665) (← links)
- Ciclosporin population pharmacokinetics and Bayesian estimation in thoracic transplant recipients (Q45188607) (← links)
- Individualization of immunosuppressive therapy: I. Sirolimus improves outcomes in African-American renal transplant recipients (Q46873844) (← links)
- INTENSIVE OBSERVATION OF TOXIC SIDE EFFECTS AFTER SEVERAL-YEAR OF CYCLOSPORIN TREATMENT IN KIDNEY TRANSPLANT PATIENT. (Q47169168) (← links)
- Validation of Sparse Sampling Strategies to Estimate Cyclosporine A Area Under the Concentration-Time Curve Using Either a Specific Radioimmunoassay or High-Performance Liquid Chromography Method (Q51673782) (← links)
- Abbreviated tacrolimus area-under-the-curve monitoring for renal transplant recipients (Q52080444) (← links)
- Optimization of cyclosporine therapy with new therapeutic drug monitoring strategies: report from the International Neoral TDM Advisory Consensus Meeting (Vancouver, November 1997). (Q52237037) (← links)
- A Population Pharmacokinetic Model of Cyclosporine in the Early Postoperative Phase in Patients With Liver Transplants, and Its Predictive Performance With Bayesian Fitting (Q52244875) (← links)
- Cyclosporine absorption profiling and therapeutic drug monitoring using C(2) blood levels in stable renal allograft recipients. (Q52956147) (← links)
- Effect of grapefruit juice on cyclosporin A pharmacokinetics in pediatric renal transplant patients. (Q53901793) (← links)
- Cyclosporine A monitoring ? how to account for twice and three times daily dosing (Q61764257) (← links)
- Current opinions on therapeutic drug monitoring of immunosuppressive drugs (Q73194059) (← links)
- Abbreviated kinetic profiles to estimate exposure to CyA in renal allograft recipients treated with Sandimmun-Neoral (Q73277943) (← links)
- An Abbreviated Area-Under-the-Curve Monitoring for Tacrolimus in Patients With Liver Transplants (Q74477343) (← links)
- Nine-month follow-up of SangCya (Sang-35) in kidney transplant patients after conversion from Sandimmune (Q74616108) (← links)
- Optimization of cyclosporine therapy in renal transplantation (Q77175919) (← links)
- Conventional versus neoral cyclosporine in renal transplantation (Q77176018) (← links)
- Improving the therapeutic monitoring of cyclosporin A (Q77322677) (← links)
- The evolution of therapeutic drug monitoring of cyclosporine (Q77369533) (← links)
- Cyclosporine peak concentration in relation to the four-hour absorption phase in pediatric renal graft recipients (Q77369587) (← links)